# US 2024/0399068 A1 · Dose control system for injectable-drug delivery devices and associated methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0399068 A1
- Document ID: US20240399068A1
- Status: Published application
- Kind: A1
- Application number: 18/800,828
- Filed: 2024-08-12
- Published: 2024-12-05
- Earliest claimed: 2019-07-22
- Assignees: Biocorp Production
- Applicants: Biocorp Production S.A.S.
- Inventors: Lionel ALDON; Alain MARCOZ
- Web page: https://patentgrep.com/patent/US20240399068A1

## CPC

- A61M 5/31533: {Dosing mechanisms, i.e. setting a dose (administrating mechanisms A61M5/31565)}
- A61M 5/31568: {Means keeping track of the total dose administered, e.g. since the cartridge was inserted}
- A61M 5/20: Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 takes precedence)
- A61M 5/3155: {by rotational movement of dose setting member, e.g. during setting or filling of a syringe}
- A61M 5/31553: {without axial movement of dose setting member}
- G01B 7/30: for measuring angles or tapers; for testing the alignment of axes
- G01D 5/145: {influenced by the relative movement between the Hall device and magnetic fields (see G01R33/06)}
- G05B 13/041: {in which a variable is automatically adjusted to optimise the performance}
- G16H 20/17: delivered via infusion or injection
- G16H 40/63: for local operation
- A61M 5/31525: {Dosing (burettes, pipettes B01L3/02)}
- A61M 2005/3126: {related to dosing}
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/3368: Temperature
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/50: with microprocessors or computers
- A61M 2205/60: with identification means
- A61M 2205/6054: Magnetic identification systems
- G01D 18/004: {Continuous recalibration}
- G01D 18/008: {with calibration coefficients stored in memory}
- G01D 2205/22: by converting the rotary movement into a linear movement
- G01R 33/0017: {Means for compensating offset magnetic fields or the magnetic flux to be measured; Means for generating calibration magnetic fields}
- G01R 33/02: Measuring direction or magnitude of magnetic fields or magnetic flux (G01R33/20 takes precedence)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G01B: MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS
- G01D: MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
- G05B: CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS (systems for controlling or regulating non-electric variables G05D; systems for regulating electric or magnetic variables G05F; control devices or systems insofar as characterised by mechanical features only G05G)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)

## Abstract

The invention relates to a dose control system configured for an injectable drug delivery device. The device comprises a substantially disk-shaped diametral single-dipole magnet removably attachable, or permanently fixed, to a rotatable dose wheel at a proximal extremity of a drug delivery device body, a housing removably attachable to the proximal extremity of the drug delivery body and comprising at least a first and a second magnetic field measurement means configured to measure the magnetic field produced by the magnet. An integrated control unit is connected to the magnetic field measurement means and is configured to process information received therefrom. The magnetic field measurement means are located in the housing in a displaced axial relationship relative to the longitudinal axis of the drug delivery body and the magnet. The magnet is configured to co-rotate with the dose setting wheel around the longitudinal axis of the drug delivery body and the integrated control unit is further configured to provide a normalized vector with regard to the displaced axial relationship of the magnetic field measurement means, said normalized vector being derived from the measured magnetic field generated by the rotation of the magnet and measured by the magnetic field measurement means. A dose setting is calculated from said normalized vector.

## Claims

### Claim 1

A method for calculating a dose setting in a dose control system, comprising:
measuring a magnetic field (CM) produced by a rotatable substantially disk-shaped diametral single-dipole magnet with at least a first (m1) and a second (m2) magnetometer disposed in displaced axial alignment to an axis of rotation of said magnet;
calculating a resulting magnetic field pseudo-vector (CR);
calculating an angle of rotation to an iso-normal plane of projection for said magnetic field pseudo-vector;
transforming said magnetic field pseudo-vector with said angle of rotation to create, by rotation and projection, an iso-normal corrected magnetic field pseudo-vector (CR2); and
calculating from said corrected iso-normal magnetic field pseudo-vector an angle of rotation of said magnet about said axis of rotation.

### Claim 2 (depends on 1)

The method of claim 1, further comprising correcting said measured magnetic field CMm1 and CMm2.

### Claim 3 (depends on 1)

The method of claim 1, further comprising calculating a reference position of said magnet on a normal corresponding to a translated position of said magnet along said axis of rotation.

### Claim 4

A dose control system for a drug delivery device, comprising:
a rotatable dose setting wheel located on the drug delivery device;
a single-dipole magnet removably attachable, or permanently fixed, to the rotatable dose setting wheel;
at least a first and a second magnetometer configured to measure a magnetic field produced by the single-dipole magnet,
wherein the at least first and second magnetometers are arranged in a displaced axial relationship relative to a longitudinal axis of the drug delivery device and an axis of rotation of the single-dipole magnet, and
wherein the single-dipole magnet is configured to co-rotate with the dose setting wheel around the longitudinal axis; and
an integrated control unit connected to the at least first and second magnetometers and configured to:
calculate offset values for the at least first and second magnetometers from a series of points generated by corresponding vectors of the measured magnetic fields resembling a sphericized cloud of points in three dimensions,
provide a normalized vector with regard to the displaced axial relationship of the at least first and second magnetometers, the normalized vector being derived from the measured magnetic field generated by the rotation of the single-dipole magnet and measured by the at least first and second magnetometers, and
calculate a dose setting from the normalized vector.

### Claim 5 (depends on 4)

The dose control system of claim 4, wherein the drug delivery device is an injectable drug delivery device.

### Claim 6 (depends on 4)

The dose control system of claim 4, wherein the rotatable dose setting wheel is rotatable about the longitudinal axis of the drug delivery device.

### Claim 7 (depends on 4)

The dose control system of claim 4, wherein the drug delivery device has a distal and proximal extremity, wherein the rotatable dose setting wheel is located at the proximal extremity.

### Claim 8 (depends on 7)

The dose control system of claim 7, wherein the at least first and second magnetometers are located in a removably attachable housing adjacent to the proximal extremity of the drug delivery device.

### Claim 9 (depends on 8)

The dose control system of claim 8, wherein the at least first and second magnetometers are located distally of the proximal extremity of the drug delivery device.

### Claim 10 (depends on 8)

The dose control system of claim 8, wherein the at least first and second magnetometers are located on a support structure within the housing.

### Claim 11 (depends on 4)

The dose control system of claim 4, wherein the magnet is substantially disk-shaped.

### Claim 12 (depends on 4)

The dose control system of claim 4, further comprising an integrated processing unit configured to correct magnetic field values measured by the at least first and second magnetometers as a function of the displaced axial relationship of at least first and second magnetometers relative to the single-dipole magnet.

### Claim 13 (depends on 12)

The dose control system of claim 12, wherein the integrated processing unit is further configured to correct the magnetic field values measured by the at least first and second magnetometers by applying a rotation about the axis of rotation to a pseudo-vector representing a resultant pseudo-magnetic field calculated from the measured magnetic fields of the first and second magnetometers to bring the pseudo-vector into an iso-normal projection plane, wherein the at least first and second magnetometers are configured to measure the magnetic field produced by the single-dipole magnet via determination of a rotational movement of the single-dipole magnet and without determination of an axial position of the single-dipole magnet.

### Claim 14 (depends on 4)

The dose control system of claim 4, wherein the integrated control unit is further configured to calculate corrected offset values for the first and second magnetometers.

### Claim 15 (depends on 4)

The dose control system of claim 4, wherein the first magnetometer and the second magnetometer are configured to simultaneously and independently measure the magnetic field produced as the single-dipole magnet is rotated about the longitudinal axis.

### Claim 16 (depends on 4)

The dose control system of claim 4, further comprising a communication unit configured to enable communication of information from the integrated control unit with a remote and/or local data processing system.

### Claim 17 (depends on 16)

The dose control system of claim 16, wherein the remote and/or local data processing system comprises a smartphone application.

### Claim 18 (depends on 4)

The dose control system of claim 4, further comprising an autonomous power supply.

### Claim 19 (depends on 4)

The dose control system of claim 4, further comprising a temperature detector.

### Claim 20 (depends on 4)

The dose control system of claim 4, wherein a field strength of the single-dipole magnet and a positioning of the first and second magnetometers are configured in such a way that a difference of at least 100 microTesla (μT) is present between the values measured at the first and second magnetometers.
